"Zhongyuan Pharmaceutical Moon Moon Talk" first issue

"Since the" New Medicine Reform ", the construction of the drug policy system has two clear main lines: 'Quality Guarantee' and 'Affordability', and the corresponding" quality lifting 'and' control "of it became the reform of my country's pharmaceutical field. Two main goals. "On September 8th, the first phase of the" Central Plains Pharmaceutical Moon and Moon "was lectured. Dong Wei, director of the Director of the Pharmaceutical and Political Department of the Henan Provincial Health and Health Commission, gave a opening speech and conducted one of the above two main goals. Elapse.

On the same day, the first phase of the "Central Phaseral Pharmaceutical Moon Moon Talk" co -organized by the Henan Provincial Health and Health Commission and hosted by the Pharmaceutical and Health News Agency, and co -organized by Huizhi Pharmaceutical Co., Ltd. through online form. Dong Wei and editor -in -chief of the Medical Health Newspaper Chen Linjun attended the event and delivered a speech; Li Zhiye, deputy dean of Zhengzhou University Second Affiliated Hospital; Jin Chunlin, Director of the Shanghai Health and Healthy Development Research Center, and Wang Li, director of Henan Provincial People's Hospital, were invited to perform "National Medicine The influence and analysis of centralized procurement policies "" Henan Provincial Medical Institutions Implementation of Pharmaceutical Experts Pharmaceutical Expert Consensus "lectures; 73,700 relevant personnel from pharmacy, medical insurance departments at all levels, medical institutions, medical insurance departments, and medical insurance were online. study.

Basic people's livelihood. With the development of economic and social development and the continuous deepening of the reform of the medical and health system, the demand and expectations of the people of the people are getting higher and higher, and the construction of the drug supply guarantee system is facing a new situation.

"Quality" is to improve the quality of medicine. Dong Wei believes that this is mainly reflected in the research and development and production links, and implemented by improving quality standards and encouraging innovative drugs. Among them, the improvement of quality standards is to ensure the quality and safety of drugs by constructing a drug production and operating quality guarantee system, and at the same time cooperate with special production circulation politics and supervision behavior.

Through quality and efficacy consistency evaluation, eliminate low -level generic drugs, optimize the approval and review process, and improve the efficiency of approval and review of new drugs; use drug registration classification reform, clinical trial reform, connecting international drug research and development technology and standards, etc. R & D; at the same time, provide corresponding incentive policies in the use of drugs, procurement, and included in the medical insurance directory, thereby promoting the improvement of my country's overall drug quality.

"The" control fee 'is mainly carried out from the two aspects of' price 'and' quantity '. "Dong Wei further explained that the price reduction must be started from three links: the production link should be encouraged to clinical on the basis of the consistency evaluation of generic drugs. Use generic drugs, and at the same time strengthen the supply of supplies for low -priced commonly used drugs; the circulation link must squeeze the price "moisture"; the procurement session should be a centralized procurement system, the implementation of the volume procurement, the implementation of the region and even the nationwide procurement price linkage, etc. Methods continue to pressure the price of drugs.

In terms of "quantity", it is mainly related to the use link and payment link. Dong Wei said that on the one hand, through the use of the "zero -difference rate" sales of drugs, the motivation to reduce the "big prescription" behavior of medical staff; on the other hand, through the management of reasonable medication, the hospital's prescription behavior is standardized. The payment session mainly restricts the prescription behavior through the monitoring and assessment of the drug use of public hospitals and medical personnel through the medical insurance fund, and promotes public hospitals in terms of control's fees through reform.

In fact, in terms of drug control, the country has also continued to make efforts. In recent years, the drug concentrated procurement policy implemented in recent years has played an important role in improving people's livelihood, promoting the reform of the "three medical linkages", and promoting the healthy development of the pharmaceutical industry. Essence

"The significance of the purchase of quantitative procurement is to determine the contractual relationship between the price and the amount, and realize the" volume and price linked '' '' with quantity to change the price. : For the society, the interest chain of the drug circulation is cut off, standardized delivery behavior and procurement behavior; from the perspective of the patient, it greatly reduces the economic burden; for enterprises, it has reduced sales costs and cost transactions; for hospitals It helps to achieve the fee control indicators, and it is also positive for the construction of medical staff; from the perspective of medical insurance, medical insurance costs are saved.

Jin Chunlin admits that there are still some problems in the implementation of the drug concentration and volume procurement policy, which needs to attract everyone's attention. The first is that doctors are trending to win bidding medicines, and doctors and patients have a difference in the awareness of the bidding drugs. The second is the feedback of patients, and there are regional differences in the acceptance of the bidders. Third, the hospital attaches great importance to the supervision of the use of bidders. In some areas, more hard management measures have been adopted, but to a certain extent, the right to doctors' prescriptions and patient selection of medication is limited. Fourth, the exclusive winning standards make some bidders facing the pressure of supply and quality control, and the quality of drug quality has increased. Fifth, low -cost bids lead to low -profit operation of the enterprise, and the continuous quality improvement is affected.

At the same time, Jin Chunlin gives some optimization suggestions: increase the interpretation and publicity of the procurement policy; formulate the management strategy of refined use of the bidding drugs; strengthen the shortage of supply to monitor the supply of bidding drugs; and continue to follow up the potential quality risks of winning products.

"Scientific implementation of the centralized procurement policy is imperative!" Facing the problems existing in the implementation of the centralized procurement of drugs, Wang Li put forward his own views. At present, my country still lacks unified and standardized solutions and proposals. As of July 2022, Hubei, Sichuan, Guangdong, Inner Mongolia, Liaoning, Xinjiang, Hebei, Jiangxi and other places have released experts for implementing collection and mining work. Liaoning, Sichuan and other places have also released expert consensus. Due to the different actual situations of the provinces, there are differences in the implementation of centralized procurement of drug policies. Therefore, in combination with its own actual situation, it is necessary to explore the establishment of a set of centralized procurement of medical institutions at all levels of medical institutions in Henan Province. The "Henan Provincial Medical Institutions Implementation Policy Policy Expert Consensus" by the "Henan Provincial Medical Institutions Implementation Policy Policy Expert Consensus" by Henan Provincial Pharmaceutical Society organized and led by Henan Provincial Pharmaceutical Society organized and written by Henan Provincial Pharmaceutical Society. On July 8th, it was reviewed and approved by the Second Executive Council of the Henan Pharmaceutical Association in 2022. The consensus conducts precise classification of problems encountered by medical institutions at all levels in Henan Province in the process of implementing the drug policy, and scientifically judged corresponding solutions or guiding suggestions.

The "Central Plains Pharmaceutical Moon and Monthly" plan is planned for one month, and experts from medical insurance, medical insurance, and medical departments are invited to carry out policy interpretation, experience exchanges, and problem discussion on national drug -related policies, expert consensus, and pharmacy service capabilities. In strengthening the construction of the pharmacist team, improving the level of pharmaceutical management of medical institutions, improving pharmacist's pharmaceutical service capabilities, and further promoting reasonable medication. (Reporter Zhu Xiaojuan)

- END -